REQUEST A DEMO
Total
USD $0.00
Search more companies

Dongwha Pharm Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Dongwha Pharm Co.,Ltd. Profile Updated: July 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Dongwha Pharm Co.,Ltd. is engaged in manufacturing and distribution of medicines and pharmaceutical products including digestive system remedies, antibiotics, cardiovascular and metabolic disease treatments, non steroidal anti-inflammatory drugs, respiratory remedies, muscle relaxants, nervous system remedies, dermatological remedies and urinary system remedies. The company also offers OTC drugs such as cold remedies, dental remedies, dermatological remedies, hepatic protectors, nutrients, tonics, topical analgesics, anti-smoking agents and others. Dongwha Pharm Co.,Ltd. developed a radiopharmaceutical drug for liver cancer known as Milican Injection. The company is based in Seoul, South Korea. Dongwha Pharm Co.,Ltd. was incorporated in 1970.

Headquarters
5 Sunhwa-Dong, Jung-Gu
Seoul; Seoul; Postal Code: 100-130

Contact Details: Purchase the Dongwha Pharm Co.,Ltd. report to view the information.

Website: http://www.dong-wha.co.kr

Basic Information
Total Employees:
Purchase the Dongwha Pharm Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Dongwha Pharm Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Dongwha Pharm Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Dongwha Pharm Co.,Ltd. report to view the information.
Incorporation Date:
September 25, 1897
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
5.13%
Purchase this report to view the information.
1.89%
Purchase this report to view the information.
0.8%
Purchase this report to view the information.
0.48%
Purchase this report to view the information.
0.11%
Subsidiaries
(주)동화개발
100%
동화약품(주)
15.22%
동화지앤피(주)
Company Performance
Financial values in the chart are available after Dongwha Pharm Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
6.08%
Total operating revenue
10.73%
Operating profit (EBIT)
56.09%
EBITDA
14.43%
Net Profit (Loss) for the Period
30.78%
Total assets
22.52%
Total equity
7.5%
Operating Profit Margin (ROS)
2.8%
Net Profit Margin
1.48%
Return on Equity (ROE)
1.24%
Debt to Equity Ratio
9.81%
Quick Ratio
-0.82%
Cash Ratio
0.23%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?